{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T11:47:12Z","timestamp":1780746432274,"version":"3.54.1"},"reference-count":168,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002203","name":"Brain Tumour Charity","doi-asserted-by":"publisher","award":["GN-000693"],"award-info":[{"award-number":["GN-000693"]}],"id":[{"id":"10.13039\/501100002203","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>With increasing molecular analyses of meningiomas, there is a need to harmonize language used to capture clinical data across centers to ensure that molecular alterations are appropriately linked to clinical variables of interest. Here the International Consortium on Meningiomas presents a set of core and supplemental meningioma-specific common data elements (CDEs) to facilitate comparative and pooled analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The generation of CDEs followed the 4-phase process similar to other National Institute of Neurological Disorders and Stroke (NINDS) CDE projects: discovery, internal validation, external validation, and distribution.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The CDEs were organized into patient- and tumor-level modules. In total, 17 core CDEs (10 patient level and 7 tumor level) as well as 14 supplemental CDEs (7 patient level and 7 tumor level) were defined and described. These CDEs are now made publicly available for dissemination and adoption.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>CDEs provide a framework for discussion in the neuro-oncology community that will facilitate data-sharing for collaborative research projects and aid in developing a common language for comparative and pooled analyses. The meningioma-specific CDEs presented here are intended to be dynamic parameters that evolve with time and The Consortium welcomes international feedback for further refinement and implementation of these CDEs.<\/jats:p><\/jats:sec>","DOI":"10.1093\/neuonc\/noab259","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T20:15:44Z","timestamp":1637007344000},"page":"683-693","source":"Crossref","is-referenced-by-count":18,"title":["Consensus core clinical data elements for meningiomas (v2021.1)"],"prefix":"10.1093","volume":"24","author":[{"given":"Farshad","family":"Nassiri","sequence":"first","affiliation":[{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada"},{"name":"Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8998-7443","authenticated-orcid":false,"given":"Justin Z","family":"Wang","sequence":"additional","affiliation":[{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada"},{"name":"Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolyn","family":"Au","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Barnholtz-Sloan","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Jenkinson","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Drummond","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Royal Melbourne Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueren","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Henry Ford Health System, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Snyder","sequence":"additional","affiliation":[{"name":"Department of Neurology, Henry Ford Health System, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Brastianos","sequence":"additional","affiliation":[{"name":"Dana Farber\/Harvard Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Santarius","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Cambridge University Hospitals, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suganth","family":"Suppiah","sequence":"additional","affiliation":[{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada"},{"name":"Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Poisson","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Henry Ford Health System, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Gaillard","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek S","family":"Tsang","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Aldape","sequence":"additional","affiliation":[{"name":"National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelareh","family":"Zadeh","sequence":"additional","affiliation":[{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada"},{"name":"Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"issue":"6","key":"2022050520153792800_CIT0001","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"26","key":"2022050520153792800_CIT0002","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas","volume":"372","author":"Brat","year":"2015","journal-title":"N Engl J Med"},{"key":"2022050520153792800_CIT0003","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro Oncol"},{"issue":"3","key":"2022050520153792800_CIT0004","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng.2526","article-title":"Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations","volume":"45","author":"Brastianos","year":"2013","journal-title":"Nat Genet."},{"issue":"6123","key":"2022050520153792800_CIT0005","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science."},{"issue":"10","key":"2022050520153792800_CIT0006","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ng.3651","article-title":"Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas","volume":"48","author":"Clark","year":"2016","journal-title":"Nat Genet."},{"issue":"1","key":"2022050520153792800_CIT0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms14433","article-title":"Integrated genomic analyses of de novo pathways underlying atypical meningiomas","volume":"8","author":"Harmanc\u0131","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"2022050520153792800_CIT0008","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/bpa.12110","article-title":"High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression","volume":"24","author":"Goutagny","year":"2014","journal-title":"Brain Pathol."},{"issue":"5","key":"2022050520153792800_CIT0009","doi-asserted-by":"crossref","first-page":"djv377","DOI":"10.1093\/jnci\/djv377","article-title":"TERT promoter mutations and risk of recurrence in meningioma","volume":"108","author":"Sahm","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2022050520153792800_CIT0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-020-02188-w","article-title":"CDKN2A\/B homozygous deletion is associated with early recurrence in meningiomas","volume":"140","author":"Sievers","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"4","key":"2022050520153792800_CIT0011","first-page":"535","article-title":"Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas","volume":"19","author":"Shankar","year":"2017","journal-title":"Neuro Oncol."},{"issue":"11","key":"2022050520153792800_CIT0012","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/neuonc\/nox094","article-title":"BAP1 mutations in high-grade meningioma: implications for patient care","volume":"19","author":"Shankar","year":"2017","journal-title":"Neuro Oncol."},{"issue":"6","key":"2022050520153792800_CIT0013","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/1740774516653238","article-title":"Improving the value of clinical research through the use of common data elements","volume":"13","author":"Sheehan","year":"2016","journal-title":"Clin Trials."},{"issue":"11","key":"2022050520153792800_CIT0014","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.apmr.2010.07.238","article-title":"Common data elements in radiologic imaging of traumatic brain injury","volume":"91","author":"Duhaime","year":"2010","journal-title":"Arch Phys Med Rehabil."},{"issue":"6","key":"2022050520153792800_CIT0015","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1528-1167.2011.03018.x","article-title":"Common data elements in epilepsy research: development and implementation of the NINDS epilepsy CDE project","volume":"52","author":"Loring","year":"2011","journal-title":"Epilepsia."},{"issue":"11","key":"2022050520153792800_CIT0016","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.apmr.2010.07.232","article-title":"Common data elements for traumatic brain injury: recommendations from the interagency working group on demographics and clinical assessment","volume":"91","author":"Maas","year":"2010","journal-title":"Arch Phys Med Rehabil."},{"issue":"6","key":"2022050520153792800_CIT0017","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1055\/s-0038-1634121","article-title":"The common data elements for cancer research: remarks on functions and structure","volume":"45","author":"Nadkarni","year":"2006","journal-title":"Methods Inf Med."},{"issue":"10","key":"2022050520153792800_CIT0018","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2217\/fon-2015-0043","article-title":"Opportunities and challenges in leveraging electronic health record data in oncology","volume":"12","author":"Berger","year":"2016","journal-title":"Future Oncol."},{"issue":"3","key":"2022050520153792800_CIT0019","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/1740774512438980","article-title":"National Institute of Neurological Disorders and Stroke common data element project \u2013 approach and methods","volume":"9","author":"Grinnon","year":"2012","journal-title":"Clinical Trials"},{"issue":"12","key":"2022050520153792800_CIT0020","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/PAS.0b013e31829d7f35","article-title":"Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR)","volume":"37","author":"Scolyer","year":"2013","journal-title":"Am J Surg Pathol."},{"issue":"3","key":"2022050520153792800_CIT0021","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.4103\/jfmpc.jfmpc_931_19","article-title":"Common data elements of breast cancer for research databases: a systematic review","volume":"9","author":"Mirbagheri","year":"2020","journal-title":"J Family Med Prim Care."},{"key":"2022050520153792800_CIT0022","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1200\/CCI.20.00059","article-title":"Improving cancer data interoperability: the promise of the Minimal Common Oncology Data Elements (mCODE) Initiative","volume":"4","author":"Osterman","year":"2020","journal-title":"JCO Clin Cancer Inform."},{"issue":"5","key":"2022050520153792800_CIT0023","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3414\/ME14-02-0030","article-title":"A generic data harmonization process for cross-linked research and network interaction. Construction and application for the lung cancer phenotype database of the German Center for Lung Research","volume":"54","author":"Firnkorn","year":"2015","journal-title":"Methods Inf Med."},{"issue":"3","key":"2022050520153792800_CIT0024","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.prro.2018.01.012","article-title":"Radiation therapy for the whole breast: executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline","volume":"8","author":"Smith","year":"2018","journal-title":"Pract Radiat Oncol."},{"key":"2022050520153792800_CIT0025","volume-title":"NINDS Common Data Elements. Chiari I Malformation Standards","author":"National Institutes of Health","year":"2018"},{"issue":"2","key":"2022050520153792800_CIT0026","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform."},{"issue":"2","key":"2022050520153792800_CIT0027","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jbi.2012.10.006","article-title":"Procurement of shared data instruments for Research Electronic Data Capture (REDCap)","volume":"46","author":"Obeid","year":"2013","journal-title":"J Biomed Inform."},{"issue":"11","key":"2022050520153792800_CIT0028","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2105\/AJPH.90.11.1714","article-title":"Race\/ethnicity and OMB Directive 15: implications for state public health practice","volume":"90","author":"Friedman","year":"2000","journal-title":"Am J Public Health."},{"issue":"4","key":"2022050520153792800_CIT0029","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3171\/2016.2.JNS152611","article-title":"Surgery for meningioma in the elderly and long-term survival: comparison with an age- and sex-matched general population and with younger patients","volume":"126","author":"Brokinkel","year":"2017","journal-title":"J Neurosurg."},{"issue":"Suppl 1","key":"2022050520153792800_CIT0030","doi-asserted-by":"crossref","first-page":"i32","DOI":"10.1093\/neuonc\/noy152","article-title":"Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life","volume":"21","author":"Nassiri","year":"2019","journal-title":"Neuro Oncol."},{"issue":"3","key":"2022050520153792800_CIT0031","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/14737175.2018.1429920","article-title":"Current treatment options for meningioma","volume":"18","author":"Apra","year":"2018","journal-title":"Expert Rev Neurother."},{"issue":"Suppl 1","key":"2022050520153792800_CIT0032","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.21037\/cco.2017.06.10","article-title":"Current and emerging principles in surgery for meningioma","volume":"6","author":"Bi","year":"2017","journal-title":"Chin Clin Oncol."},{"issue":"1","key":"2022050520153792800_CIT0033","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/neuonc\/noy137","article-title":"Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group","volume":"21","author":"Huang","year":"2019","journal-title":"Neuro Oncol."},{"issue":"1","key":"2022050520153792800_CIT0034","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/cncr.30975","article-title":"Quality of life after surgery for intracranial meningioma","volume":"124","author":"Benz","year":"2018","journal-title":"Cancer."},{"issue":"2","key":"2022050520153792800_CIT0035","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s10143-020-01282-7","article-title":"Is surgery justified for 80-year-old or older intracranial meningioma patients? A systematic review","volume":"44","author":"Rautalin","year":"2021","journal-title":"Neurosurg Rev."},{"key":"2022050520153792800_CIT0036","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1016\/j.wneu.2017.09.161","article-title":"Intracranial meningioma in patients age &lt;35 years: evolution of the disease in the era of human immunodeficiency virus infection","volume":"109","author":"Motebejane","year":"2018","journal-title":"World Neurosurg."},{"issue":"1","key":"2022050520153792800_CIT0037","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s41999-017-0015-1","article-title":"Meningioma surgery in younger and older adults: patient profile and surgical outcomes","volume":"9","author":"Slot","year":"2018","journal-title":"Eur Geriatr Med."},{"issue":"1","key":"2022050520153792800_CIT0038","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3171\/2017.2.PEDS16497","article-title":"Pediatric meningiomas: 65-year experience at a single institution","volume":"20","author":"Grossbach","year":"2017","journal-title":"J Neurosurg Pediatr."},{"issue":"3","key":"2022050520153792800_CIT0039","first-page":"320","article-title":"Return to work following meningioma surgery: a Swedish nationwide registry-based matched cohort study","volume":"7","author":"Thurin","year":"2020","journal-title":"Neurooncol Pract."},{"issue":"1","key":"2022050520153792800_CIT0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","article-title":"Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review","volume":"122","author":"Rogers","year":"2015","journal-title":"J Neurosurg."},{"issue":"1","key":"2022050520153792800_CIT0041","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuchi.2014.05.006","article-title":"Epidemiology of meningiomas","volume":"64","author":"Baldi","year":"2018","journal-title":"Neurochirurgie."},{"issue":"2","key":"2022050520153792800_CIT0042","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.mayocp.2018.07.026","article-title":"Factors associated with meningioma detected in a population-based sample","volume":"94","author":"Cerhan","year":"2019","journal-title":"Mayo Clin Proc."},{"issue":"2","key":"2022050520153792800_CIT0043","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.critrevonc.2008.01.010","article-title":"Meningioma","volume":"67","author":"Marosi","year":"2008","journal-title":"Crit Rev Oncol Hematol."},{"issue":"14","key":"2022050520153792800_CIT0044","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1002\/cam4.2516","article-title":"Trends in intracranial meningioma incidence in the United States, 2004-2015","volume":"8","author":"Lin","year":"2019","journal-title":"Cancer Med"},{"issue":"5","key":"2022050520153792800_CIT0045","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3171\/jns.2003.99.5.0848","article-title":"Sex steroid hormone exposures and risk for meningioma","volume":"99","author":"Jhawar","year":"2003","journal-title":"J Neurosurg."},{"issue":"12","key":"2022050520153792800_CIT0046","doi-asserted-by":"crossref","first-page":"e83261","DOI":"10.1371\/journal.pone.0083261","article-title":"Reproductive and exogenous hormone factors in relation to risk of meningioma in women: a meta-analysis","volume":"8","author":"Qi","year":"2013","journal-title":"PLoS One."},{"issue":"6","key":"2022050520153792800_CIT0047","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1055\/s-0038-1676788","article-title":"Racial differences in disease presentation and management of intracranial meningioma","volume":"80","author":"Anzalone","year":"2019","journal-title":"J Neurol Surg B Skull Base."},{"issue":"3","key":"2022050520153792800_CIT0048","first-page":"e7304","article-title":"Inequalities in meningioma survival: results from the national cancer database","volume":"12","author":"Yang","year":"2020","journal-title":"Cureus."},{"key":"2022050520153792800_CIT0049","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/j.wneu.2020.02.120","article-title":"Association of race with survival in intracranial World Health Organization Grade II and III Meningioma in the United States: systematic literature review","volume":"138","author":"Elder","year":"2020","journal-title":"World Neurosurg."},{"issue":"3","key":"2022050520153792800_CIT0050","doi-asserted-by":"crossref","first-page":"E461","DOI":"10.1093\/neuros\/nyy610","article-title":"Malignant meningioma: an international multicentre retrospective study","volume":"85","author":"Champeaux","year":"2019","journal-title":"Neurosurgery."},{"issue":"1","key":"2022050520153792800_CIT0051","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/sj.bjc.6604438","article-title":"Is the incidence of meningiomas underestimated? A regional survey","volume":"99","author":"Larjavaara","year":"2008","journal-title":"Br J Cancer."},{"issue":"4","key":"2022050520153792800_CIT0052","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1227\/00006123-198910000-00006","article-title":"Steroid hormone receptors in meningiomas of Chinese patients","volume":"25","author":"Lee","year":"1989","journal-title":"Neurosurgery."},{"issue":"5","key":"2022050520153792800_CIT0053","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/neuonc\/nos013","article-title":"Impaired survival and long-term neurological problems in benign meningioma","volume":"14","author":"van Alkemade","year":"2012","journal-title":"Neuro Oncol."},{"issue":"2","key":"2022050520153792800_CIT0054","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00701-019-03799-3","article-title":"Neurosurgical treatment and outcome patterns of meningioma in Sweden: a nationwide registry-based study","volume":"161","author":"Corell","year":"2019","journal-title":"Acta Neurochir (Wien)."},{"key":"2022050520153792800_CIT0055","doi-asserted-by":"crossref","first-page":"101562","DOI":"10.1016\/j.canep.2019.07.001","article-title":"Incidence, mortality and outcome of meningiomas: a population-based study from Germany","volume":"62","author":"Holleczek","year":"2019","journal-title":"Cancer Epidemiol."},{"issue":"15","key":"2022050520153792800_CIT0056","doi-asserted-by":"crossref","first-page":"E886","DOI":"10.1097\/BRS.0000000000000974","article-title":"Descriptive epidemiology of spinal meningiomas in the United States","volume":"40","author":"Kshettry","year":"2015","journal-title":"Spine (Phila Pa 1976)"},{"issue":"11","key":"2022050520153792800_CIT0057","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111633","article-title":"The role of Merlin\/NF2 loss in meningioma biology","volume":"11","author":"Lee","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"3","key":"2022050520153792800_CIT0058","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","article-title":"Epidemiology and etiology of meningioma","volume":"99","author":"Wiemels","year":"2010","journal-title":"J Neurooncol."},{"key":"2022050520153792800_CIT0059","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/B978-0-444-52891-9.00039-7","article-title":"Neurofibromatosis","volume":"111","author":"Korf","year":"2013","journal-title":"Handb Clin Neurol."},{"issue":"21","key":"2022050520153792800_CIT0060","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1200\/JCO.2016.71.7199","article-title":"CNS tumors in neurofibromatosis","volume":"35","author":"Campian","year":"2017","journal-title":"J Clin Oncol."},{"issue":"12","key":"2022050520153792800_CIT0061","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1158\/1078-0432.CCR-17-0590","article-title":"Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 2 and related disorders","volume":"23","author":"Evans","year":"2017","journal-title":"Clin Cancer Res."},{"issue":"3","key":"2022050520153792800_CIT0062","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s11060-018-2922-5","article-title":"Effect of lapatinib on meningioma growth in adults with neurofibromatosis type 2","volume":"139","author":"Osorio","year":"2018","journal-title":"J Neurooncol."},{"issue":"2","key":"2022050520153792800_CIT0063","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020690","article-title":"Neurofibromatosis type 2 (NF2) and the implications for vestibular schwannoma and meningioma pathogenesis","volume":"22","author":"Bachir","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2022050520153792800_CIT0064","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11060-010-0339-x","article-title":"Meningiomas and neurofibromatosis","volume":"99","author":"Goutagny","year":"2010","journal-title":"J Neurooncol."},{"key":"2022050520153792800_CIT0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/B978-0-12-804280-9.00007-X","article-title":"Inherited genetic syndromes and meningiomas","volume":"169","author":"Look","year":"2020","journal-title":"Handb Clin Neurol."},{"issue":"3","key":"2022050520153792800_CIT0066","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neuchi.2015.12.006","article-title":"Multiple meningiomas","volume":"62","author":"Terrier","year":"2016","journal-title":"Neurochirurgie."},{"key":"2022050520153792800_CIT0067","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.wneu.2017.05.120","article-title":"Neurosurgical odyssey: case of anaplastic meningiomatosis","volume":"106","author":"Giugno","year":"2017","journal-title":"World Neurosurg."},{"key":"2022050520153792800_CIT0068","article-title":"Meningiomatosis revealed by a major depressive syndrome","volume":"2015","author":"Dautricourt","year":"2015","journal-title":"BMJ Case Rep"},{"key":"2022050520153792800_CIT0069","doi-asserted-by":"crossref","first-page":"e1536","DOI":"10.1016\/j.wneu.2018.11.097","article-title":"Multiple intracranial meningiomas: a case series and review of the literature","volume":"122","author":"Ara\u00fajo Pereira","year":"2019","journal-title":"World Neurosurg"},{"key":"2022050520153792800_CIT0070","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/2152-7806.155447","article-title":"Meningiomatosis restricted to the left cerebral hemisphere with acute clinical deterioration: case presentation and discussion of treatment options","volume":"6","author":"Ohla","year":"2015","journal-title":"Surg Neurol Int."},{"issue":"6","key":"2022050520153792800_CIT0071","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3171\/2011.6.JNS11129","article-title":"Family and personal medical history and risk of meningioma","volume":"115","author":"Claus","year":"2011","journal-title":"J Neurosurg."},{"issue":"1","key":"2022050520153792800_CIT0072","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3171\/2014.10.JNS14502","article-title":"Survival in patients treated for anaplastic meningioma","volume":"123","author":"Moliterno","year":"2015","journal-title":"J Neurosurg."},{"issue":"6","key":"2022050520153792800_CIT0073","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3340\/jkns.2017.0303.008","article-title":"Prognostic factors of atypical meningioma: overall survival rate and progression free survival rate","volume":"60","author":"Lee","year":"2017","journal-title":"J Korean Neurosurg Soc."},{"key":"2022050520153792800_CIT0074","doi-asserted-by":"crossref","first-page":"35743","DOI":"10.1038\/srep35743","article-title":"Long term surgical outcome and prognostic factors of atypical and malignant meningiomas","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep."},{"issue":"1","key":"2022050520153792800_CIT0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11060-019-03278-w","article-title":"Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas","volume":"145","author":"Li","year":"2019","journal-title":"J Neurooncol."},{"issue":"1","key":"2022050520153792800_CIT0076","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3171\/jns.1984.60.1.0052","article-title":"Morbidity, mortality, and quality of life following surgery for intracranial meningiomas. A retrospective study in 257 cases","volume":"60","author":"Chan","year":"1984","journal-title":"J Neurosurg."},{"issue":"1","key":"2022050520153792800_CIT0077","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11060-019-03147-6","article-title":"Fertility treatment is associated with multiple meningiomas and younger age at diagnosis","volume":"143","author":"Shahin","year":"2019","journal-title":"J Neurooncol."},{"issue":"10","key":"2022050520153792800_CIT0078","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1586\/ern.12.108","article-title":"Chemotherapy: what is its role in meningioma?","volume":"12","author":"Sherman","year":"2012","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"2022050520153792800_CIT0079","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/CCO.0b013e328356364d","article-title":"The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma","volume":"24","author":"Chamberlain","year":"2012","journal-title":"Curr Opin Oncol."},{"issue":"Suppl 1","key":"2022050520153792800_CIT0080","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/neuonc\/noy178","article-title":"Molecular and translational advances in meningiomas","volume":"21","author":"Suppiah","year":"2019","journal-title":"Neuro Oncol."},{"issue":"Suppl 1","key":"2022050520153792800_CIT0081","doi-asserted-by":"crossref","first-page":"i18","DOI":"10.1093\/neuonc\/noy136","article-title":"Advances in multidisciplinary therapy for meningiomas","volume":"21","author":"Brastianos","year":"2019","journal-title":"Neuro Oncol."},{"issue":"6","key":"2022050520153792800_CIT0082","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/neuonc\/not330","article-title":"Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review","volume":"16","author":"Kaley","year":"2014","journal-title":"Neuro Oncol."},{"issue":"1","key":"2022050520153792800_CIT0083","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/neuonc\/nou148","article-title":"Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma","volume":"17","author":"Kaley","year":"2015","journal-title":"Neuro Oncol."},{"issue":"3","key":"2022050520153792800_CIT0084","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/1078-0432.CCR-19-2109","article-title":"Everolimus and octreotide for patients with recurrent meningioma: results from the phase II CEVOREM trial","volume":"26","author":"Graillon","year":"2020","journal-title":"Clin Cancer Res."},{"issue":"3","key":"2022050520153792800_CIT0085","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF00165657","article-title":"Chemotherapy for meningiomas","volume":"29","author":"Kyritsis","year":"1996","journal-title":"J Neurooncol."},{"issue":"1","key":"2022050520153792800_CIT0086","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/CEJ.0000000000000133","article-title":"Association of tamoxifen with meningioma: a population-based study in Sweden","volume":"25","author":"Ji","year":"2016","journal-title":"Eur J Cancer Prev."},{"key":"2022050520153792800_CIT0087","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1748-717X-9-38","article-title":"A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas","volume":"9","author":"Ferraro","year":"2014","journal-title":"Radiat Oncol."},{"key":"2022050520153792800_CIT0088","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41746-020-0219-5","article-title":"Individual-patient prediction of meningioma malignancy and survival using the Surveillance, Epidemiology, and End Results database","volume":"3","author":"Moreau","year":"2020","journal-title":"NPJ Digit Med."},{"issue":"1","key":"2022050520153792800_CIT0089","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41467-017-00174-7","article-title":"Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas","volume":"8","author":"Agnihotri","year":"2017","journal-title":"Nat Commun."},{"issue":"5","key":"2022050520153792800_CIT0090","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/FOC\/2008\/24\/5\/E7","article-title":"Radiation-induced meningioma","volume":"24","author":"Umansky","year":"2008","journal-title":"Neurosurg Focus."},{"key":"2022050520153792800_CIT0091","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/B978-0-12-804280-9.00018-4","article-title":"Radiation-induced meningiomas","volume":"169","author":"Benjamin","year":"2020","journal-title":"Handb Clin Neurol."},{"issue":"3","key":"2022050520153792800_CIT0092","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00006123-199103000-00031","article-title":"Radiation-induced meningioma","volume":"28","author":"Sridhar","year":"1991","journal-title":"Neurosurgery."},{"issue":"11","key":"2022050520153792800_CIT0093","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF00300726","article-title":"Radiation-induced meningioma","volume":"11","author":"Dweik","year":"1995","journal-title":"Childs Nerv Syst."},{"key":"2022050520153792800_CIT0094","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.wneu.2016.09.094","article-title":"Radiation-induced meningiomas: an exhaustive review of the literature","volume":"97","author":"Yamanaka","year":"2017","journal-title":"World Neurosurg"},{"issue":"6","key":"2022050520153792800_CIT0095","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/CCO.0000000000000687","article-title":"Molecular alterations in meningioma: prognostic and therapeutic perspectives","volume":"32","author":"Birzu","year":"2020","journal-title":"Curr Opin Oncol."},{"issue":"5","key":"2022050520153792800_CIT0096","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3171\/jns.2002.97.5.1078","article-title":"Radiation-induced meningioma: a descriptive study of 253 cases","volume":"97","author":"Sadetzki","year":"2002","journal-title":"J Neurosurg."},{"issue":"7","key":"2022050520153792800_CIT0097","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/jnen\/59.7.614","article-title":"Radiation-induced meningioma: a distinct molecular genetic pattern?","volume":"59","author":"Shoshan","year":"2000","journal-title":"J Neuropathol Exp Neurol."},{"issue":"1","key":"2022050520153792800_CIT0098","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11060-005-9009-9","article-title":"Radiation induced meningioma with a short latent period following high dose cranial irradiation \u2013 case report and literature review","volume":"77","author":"Choudhary","year":"2006","journal-title":"J Neurooncol."},{"key":"2022050520153792800_CIT0099","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/2152-7806.112617","article-title":"Natural history of multiple meningiomas","volume":"4","author":"Wong","year":"2013","journal-title":"Surg Neurol Int."},{"key":"2022050520153792800_CIT0100","first-page":"131962","article-title":"Multiple intracranial meningiomas: a review of the literature and a case report","volume":"2013","author":"Koech","year":"2013","journal-title":"Case Rep Surg."},{"issue":"10","key":"2022050520153792800_CIT0101","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2176\/nmc.ra.2017-0011","article-title":"Review of current evidence regarding surgery in elderly patients with meningioma","volume":"57","author":"Ikawa","year":"2017","journal-title":"Neurol Med Chir (Tokyo)."},{"issue":"8","key":"2022050520153792800_CIT0102","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00701-017-3146-8","article-title":"Meningiomas in pregnancy: timing of surgery and clinical outcomes as observed in 104 cases and establishment of a best management strategy","volume":"160","author":"Laviv","year":"2018","journal-title":"Acta Neurochir (Wien)."},{"issue":"5","key":"2022050520153792800_CIT0103","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3171\/2017.2.JNS162608","article-title":"Management of multiple meningiomas","volume":"128","author":"Tsermoulas","year":"2018","journal-title":"J Neurosurg."},{"issue":"3","key":"2022050520153792800_CIT0104","first-page":"599","article-title":"Concurrent adjacent meningioma and astrocytoma: a report of three cases and review of the literature","volume":"36","author":"Davis","year":"1995","journal-title":"Neurosurgery"},{"issue":"6","key":"2022050520153792800_CIT0105","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.3892\/ol.2016.4486","article-title":"A solitary fibrous tumor with concurrent meningioma at the same site: a case report and review of the literature","volume":"11","author":"Yan","year":"2016","journal-title":"Oncol Lett."},{"issue":"4","key":"2022050520153792800_CIT0106","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/197140091202500405","article-title":"Multiple intracranial meningiomas and cavernous hemangiomas","volume":"25","author":"Becker","year":"2012","journal-title":"Neuroradiol J."},{"issue":"3","key":"2022050520153792800_CIT0107","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s11060-017-2481-1","article-title":"The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?","volume":"133","author":"Vo\u00df","year":"2017","journal-title":"J Neurooncol."},{"issue":"2","key":"2022050520153792800_CIT0108","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11060-019-03293-x","article-title":"WHO grade of intracranial meningiomas differs with respect to patient\u2019s age, location, tumor size and peritumoral edema","volume":"145","author":"Ressel","year":"2019","journal-title":"J Neurooncol."},{"key":"2022050520153792800_CIT0109","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/B978-0-12-822198-3.00038-0","article-title":"Foramen magnum meningiomas","volume":"170","author":"Bir","year":"2020","journal-title":"Handb Clin Neurol."},{"issue":"12","key":"2022050520153792800_CIT0110","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1007\/s00701-019-04084-z","article-title":"WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma","volume":"161","author":"Maiuri","year":"2019","journal-title":"Acta Neurochir (Wien)."},{"issue":"4","key":"2022050520153792800_CIT0111","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000082209","article-title":"The significance of tumor location for Gamma Knife treatment of meningiomas","volume":"82","author":"Mindermann","year":"2004","journal-title":"Stereotact Funct Neurosurg."},{"key":"2022050520153792800_CIT0112","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.clineuro.2016.01.006","article-title":"WHO grade 1 meningioma recurrence: are location and Simpson grade still relevant?","volume":"141","author":"Gallagher","year":"2016","journal-title":"Clin Neurol Neurosurg."},{"issue":"4","key":"2022050520153792800_CIT0113","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/2018.1.FOCUS17752","article-title":"Relationship between tumor location, size, and WHO grade in meningioma","volume":"44","author":"Magill","year":"2018","journal-title":"Neurosurg Focus."},{"issue":"6","key":"2022050520153792800_CIT0114","first-page":"1194","article-title":"Tumor size predicts control of benign meningiomas treated with radiotherapy","volume":"44","author":"Connell","year":"1999","journal-title":"Neurosurgery"},{"issue":"3","key":"2022050520153792800_CIT0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ons\/opx098","article-title":"Tumor progression following petroclival meningioma subtotal resection: a volumetric study","volume":"14","author":"Hunter","year":"2018","journal-title":"Oper Neurosurg (Hagerstown)."},{"issue":"5","key":"2022050520153792800_CIT0116","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/neuonc\/not325","article-title":"Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype","volume":"16","author":"Domingues","year":"2014","journal-title":"Neuro Oncol."},{"issue":"5","key":"2022050520153792800_CIT0117","first-page":"1029","article-title":"Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients","volume":"49","author":"Stafford","year":"2001","journal-title":"Neurosurgery"},{"issue":"3","key":"2022050520153792800_CIT0118","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00701-016-3071-2","article-title":"Volumetric growth rates of meningioma and its correlation with histological diagnosis and clinical outcome: a systematic review","volume":"159","author":"Fountain","year":"2017","journal-title":"Acta Neurochir (Wien)."},{"issue":"2","key":"2022050520153792800_CIT0119","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00701-013-1923-6","article-title":"Simpson grade: an opportunity to reassess the need for complete resection of meningiomas","volume":"156","author":"Heald","year":"2014","journal-title":"Acta Neurochir (Wien)."},{"key":"2022050520153792800_CIT0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/2020.6.JNS201904","article-title":"The Simpson grade: abandon the scale but preserve the message","author":"Schwartz","year":"2020","journal-title":"J Neurosurg"},{"key":"2022050520153792800_CIT0121","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.1016\/j.wneu.2017.12.178","article-title":"Agreement between extent of meningioma resection based on surgical Simpson grade and based on postoperative magnetic resonance imaging findings","volume":"111","author":"Slot","year":"2018","journal-title":"World Neurosurg."},{"issue":"5","key":"2022050520153792800_CIT0122","first-page":"819","article-title":"Simpson grading as predictor of meningioma recurrence","volume":"68","author":"Quddusi","year":"2018","journal-title":"J Pak Med Assoc."},{"issue":"1","key":"2022050520153792800_CIT0123","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3171\/2012.1.JNS112319","article-title":"Simpson grade and MIB-1","volume":"117","author":"Heros","year":"2012","journal-title":"J Neurosurg"},{"issue":"5","key":"2022050520153792800_CIT0124","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3171\/2010.2.JNS10280","article-title":"Simpson grade and treatment","volume":"113","author":"Heros","year":"2010","journal-title":"J Neurosurg"},{"key":"2022050520153792800_CIT0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/2020.6.JNS20374","article-title":"Prognostic value of the Simpson grading scale in modern meningioma surgery: barrow neurological institute experience","author":"Przybylowski","year":"2020","journal-title":"J Neurosurg"},{"issue":"1","key":"2022050520153792800_CIT0126","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","article-title":"The recurrence of intracranial meningiomas after surgical treatment","volume":"20","author":"Simpson","year":"1957","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"3","key":"2022050520153792800_CIT0127","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-2007-970554","article-title":"Predicting the probability of meningioma recurrence in the preoperative and early postoperative period: a multivariate analysis in the midterm follow-up","volume":"17","author":"Ildan","year":"2007","journal-title":"Skull Base."},{"issue":"9","key":"2022050520153792800_CIT0128","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","article-title":"EANO guidelines for the diagnosis and treatment of meningiomas","volume":"17","author":"Goldbrunner","year":"2016","journal-title":"Lancet Oncol."},{"issue":"2","key":"2022050520153792800_CIT0129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuchi.2019.12.008","article-title":"WHO grade II meningioma: epidemiology, survival and contribution of postoperative radiotherapy in a multicenter cohort of 88 patients","volume":"66","author":"Poulen","year":"2020","journal-title":"Neurochirurgie."},{"issue":"3","key":"2022050520153792800_CIT0130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1023\/A:1006476604338","article-title":"Quality of life following surgery for intracranial meningiomas at Brigham and Women\u2019s Hospital: a study of 164 patients using a modification of the functional assessment of cancer therapy-brain questionnaire","volume":"48","author":"Kalkanis","year":"2000","journal-title":"J Neurooncol."},{"issue":"6","key":"2022050520153792800_CIT0131","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s007010170059","article-title":"Quality of life in patients after meningioma resection","volume":"143","author":"Mohsenipour","year":"2001","journal-title":"Acta Neurochir (Wien)."},{"issue":"7","key":"2022050520153792800_CIT0132","first-page":"897","article-title":"Impaired health-related quality of life in meningioma patients \u2013 a systematic review","volume":"19","author":"Zamanipoor Najafabadi","year":"2017","journal-title":"Neuro Oncol."},{"issue":"4","key":"2022050520153792800_CIT0133","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.wneu.2015.05.032","article-title":"Treatment response and prognosis after recurrence of atypical meningiomas","volume":"84","author":"Cao","year":"2015","journal-title":"World Neurosurg."},{"key":"2022050520153792800_CIT0134","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.inat.2018.10.007","article-title":"Predictors of recurrence and postoperative outcomes in patients with non-skull base meningiomas based on modern neurosurgical standards","volume":"15","author":"Michiwaki","year":"2019","journal-title":"Interdiscip Neurosurg"},{"issue":"Suppl 1","key":"2022050520153792800_CIT0135","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.21037\/cco.2017.05.02","article-title":"Classification of meningiomas \u2013 advances and controversies","volume":"6","author":"Harter","year":"2017","journal-title":"Chin Clin Oncol."},{"issue":"7","key":"2022050520153792800_CIT0136","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1148\/rg.2017170037","article-title":"2016 updates to the WHO brain tumor classification system: what the radiologist needs to know","volume":"37","author":"Johnson","year":"2017","journal-title":"Radiographics."},{"issue":"1","key":"2022050520153792800_CIT0137","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41598-019-57254-5","article-title":"Benefits of re-do surgery for recurrent intracranial meningiomas","volume":"10","author":"Lem\u00e9e","year":"2020","journal-title":"Sci Rep."},{"issue":"3","key":"2022050520153792800_CIT0138","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3171\/2017.11.JNS172278","article-title":"Surgical outcomes after reoperation for recurrent skull base meningiomas","volume":"130","author":"Magill","year":"2018","journal-title":"J Neurosurg."},{"issue":"10","key":"2022050520153792800_CIT0139","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1586\/ern.11.38","article-title":"Medical treatment of recurrent meningiomas","volume":"11","author":"Chamberlain","year":"2011","journal-title":"Expert Rev Neurother."},{"issue":"1","key":"2022050520153792800_CIT0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11060-018-03011-z","article-title":"Large volume re-irradiation for recurrent meningioma with pulsed reduced dose rate radiotherapy","volume":"141","author":"Witt","year":"2019","journal-title":"J Neurooncol."},{"issue":"1","key":"2022050520153792800_CIT0141","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/1971400917744885","article-title":"Radiosurgery and stereotactic radiotherapy with cyberknife system for meningioma treatment","volume":"31","author":"Di Franco","year":"2018","journal-title":"Neuroradiol J."},{"issue":"2","key":"2022050520153792800_CIT0142","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11060-017-2540-7","article-title":"Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma","volume":"134","author":"Lubgan","year":"2017","journal-title":"J Neurooncol."},{"issue":"2","key":"2022050520153792800_CIT0143","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3171\/2012.12.JNS12414","article-title":"The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection","volume":"119","author":"Hardesty","year":"2013","journal-title":"J Neurosurg."},{"issue":"4","key":"2022050520153792800_CIT0144","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.neuchi.2017.03.004","article-title":"Atypical meningioma. A study on recurrence and disease-specific survival","volume":"63","author":"Champeaux","year":"2017","journal-title":"Neurochirurgie."},{"issue":"1","key":"2022050520153792800_CIT0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3171\/jns.1983.58.1.0051","article-title":"The recurrence of intracranial meningiomas after surgical treatment","volume":"58","author":"Adegbite","year":"1983","journal-title":"J Neurosurg."},{"key":"2022050520153792800_CIT0146","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fonc.2020.00503","article-title":"Factors related to the post-operative recurrence of atypical meningiomas","volume":"10","author":"Ye","year":"2020","journal-title":"Front Oncol."},{"issue":"22","key":"2022050520153792800_CIT0147","doi-asserted-by":"crossref","first-page":"16087","DOI":"10.18632\/oncotarget.24498","article-title":"A gene expression signature predicts recurrence-free survival in meningioma","volume":"9","author":"Olar","year":"2018","journal-title":"Oncotarget."},{"issue":"5","key":"2022050520153792800_CIT0148","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol."},{"issue":"7","key":"2022050520153792800_CIT0149","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/neuonc\/noz061","article-title":"DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management","volume":"21","author":"Nassiri","year":"2019","journal-title":"Neuro Oncol."},{"issue":"9","key":"2022050520153792800_CIT0150","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00701-018-3593-x","article-title":"Predictors of early progression of surgically treated atypical meningiomas","volume":"160","author":"Budohoski","year":"2018","journal-title":"Acta Neurochir (Wien)."},{"issue":"3","key":"2022050520153792800_CIT0151","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11060-009-0084-1","article-title":"Patterns of failure after stereotactic radiotherapy of intracranial meningioma","volume":"98","author":"Askoxylakis","year":"2010","journal-title":"J Neurooncol."},{"issue":"9","key":"2022050520153792800_CIT0152","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/neuonc\/nox007","article-title":"Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma","volume":"19","author":"Wang","year":"2017","journal-title":"Neuro Oncol."},{"issue":"1","key":"2022050520153792800_CIT0153","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13014-019-1368-z","article-title":"Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma","volume":"14","author":"Hemmati","year":"2019","journal-title":"Radiat Oncol."},{"issue":"Suppl 1","key":"2022050520153792800_CIT0154","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.21037\/cco.2017.06.01","article-title":"Radiation therapy for WHO grade I meningioma","volume":"6","author":"Day","year":"2017","journal-title":"Chin Clin Oncol."},{"issue":"4","key":"2022050520153792800_CIT0155","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ijrobp.2019.11.028","article-title":"High-risk meningioma: initial outcomes from NRG Oncology\/RTOG 0539","volume":"106","author":"Rogers","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"2022050520153792800_CIT0156","doi-asserted-by":"crossref","first-page":"11220","DOI":"10.1038\/s41598-020-68177-x","article-title":"Histological transformation in recurrent WHO grade I meningiomas","volume":"10","author":"Corniola","year":"2020","journal-title":"Sci Rep."},{"issue":"2","key":"2022050520153792800_CIT0157","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3171\/jns.2004.101.2.0210","article-title":"Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings","volume":"101","author":"Al-Mefty","year":"2004","journal-title":"J Neurosurg."},{"issue":"1","key":"2022050520153792800_CIT0158","first-page":"vdaa129","article-title":"Malignant transformation of WHO grade I meningiomas after surgery or radiosurgery: systematic review and meta-analysis of observational studies","volume":"2","author":"Nakasu","year":"2020","journal-title":"Neurooncol Adv"},{"issue":"4","key":"2022050520153792800_CIT0159","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/jnnp-2019-322257","article-title":"Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis","volume":"91","author":"Mirian","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"3","key":"2022050520153792800_CIT0160","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11060-019-03333-6","article-title":"Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma","volume":"145","author":"Guyot","year":"2019","journal-title":"J Neurooncol."},{"key":"2022050520153792800_CIT0161","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clineuro.2017.05.002","article-title":"Genetic and epigenetic alterations in meningiomas","volume":"158","author":"Galani","year":"2017","journal-title":"Clin Neurol Neurosurg."},{"issue":"3","key":"2022050520153792800_CIT0162","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/neuonc\/noy124","article-title":"Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age","volume":"21","author":"Kok","year":"2019","journal-title":"Neuro Oncol."},{"issue":"6","key":"2022050520153792800_CIT0163","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/cncr.25591","article-title":"Anatomic location is a risk factor for atypical and malignant meningiomas","volume":"117","author":"Kane","year":"2011","journal-title":"Cancer."},{"issue":"1","key":"2022050520153792800_CIT0164","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2004-836225","article-title":"Volumetric analysis of the growth rate of incompletely resected intracranial meningiomas","volume":"66","author":"Nakamura","year":"2005","journal-title":"Zentralbl Neurochir."},{"issue":"12","key":"2022050520153792800_CIT0165","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/neuonc\/nox101","article-title":"Diagnostic challenges in meningioma","volume":"19","author":"Nowosielski","year":"2017","journal-title":"Neuro Oncol."},{"issue":"6","key":"2022050520153792800_CIT0166","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3171\/2016.4.JNS16245","article-title":"Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS\/CNS Section on Tumors survey","volume":"126","author":"Dewan","year":"2017","journal-title":"J Neurosurg."},{"key":"2022050520153792800_CIT0167","doi-asserted-by":"crossref","first-page":"iv20","DOI":"10.1093\/neuonc\/nox083.083","article-title":"Gene-12. The Children\u2019s Brain Tumor Tissue Consortium (CBTTC) infrastructure facilitates collaborative research in pediatric central nervous system tumors","volume":"19","author":"Felmeister","year":"2017","journal-title":"Neuro Oncol."},{"key":"2022050520153792800_CIT0168","volume-title":"mCODE\u2122: Minimal Common Oncology Data Elements","author":"American Society of Clinical Oncology IA","year":"2019"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noab259\/41638444\/noab259.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/24\/5\/683\/43548742\/noab259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/24\/5\/683\/43548742\/noab259.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T17:28:19Z","timestamp":1699810099000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/24\/5\/683\/6430437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":168,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,11,17]]},"published-print":{"date-parts":[[2022,5,4]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noab259","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5,1]]},"published":{"date-parts":[[2021,11,17]]}}}